Nephros

NEPH · NASDAQ

$3.52−$0.16 (−4.35%)TodayMarket closed ·
Prev close $3.68

About NEPH

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 36 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

Employees
36
Headquarters
South Orange, New Jersey
Listed
Sep 21, 2004
Sector
Industrials
Industry
Machinery

NEPH key statistics

Market cap
38.26M
Price-earnings ratio
23.00
Dividend yield
—
Average volume
39.83K
Volume
40.97K
Open price
$3.68
High today
$3.69
Low today
$3.41
52 Week high
$6.42
52 Week low
$2.66

Nephros (NEPH) at a glance

Nephros (NEPH) last traded at $3.52, with a market cap of 38.26M and a price-to-earnings ratio of 23.00.

Today the stock has traded between $3.41 and $3.69. The current price is 3.2% above the day's low and 4.6% below its high.

Volume so far is 40.97K shares, in line with the average of 39.83K shares a day.

Over the past year Nephros has ranged from $2.66 to $6.42, and now sits 23% of the way up that range.

Nephros met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.11 per share against an estimate of $0.0031.

NEPH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 876.1% on average.

  1. Q3 FY24: reported $0.02 per share against an estimate of -$0.0204
  2. Q4 FY24: reported $0.03 per share against an estimate of -$0.0153
  3. Q1 FY25: reported $0.05 per share against an estimate of -$0.0051
  4. Q2 FY25: reported $0.02 per share against an estimate of -$0.0255
  5. Q3 FY25: reported $0.03 per share against an estimate of -$0.0204
  6. Q4 FY25: reported $0.08 per share against an estimate of $0.0102
  7. Q1 FY26: reported $0.01 per share against an estimate of $0.0102
  8. Q2 FY26: reported $0.11 per share against an estimate of $0.0031

NEPH news

  • 12 Industrials Stocks Moving In Thursday's After-Market Session

  • 12 Industrials Stocks Moving In Monday's Pre-Market Session

  • 12 Industrials Stocks Moving In Monday's Intraday Session

  • 12 Industrials Stocks Moving In Monday's Intraday Session

  • Earnings Scheduled For November 6, 2025

  • 12 Industrials Stocks Moving In Tuesday's Pre-Market Session

  • 12 Industrials Stocks Moving In Friday's Intraday Session

  • 12 Industrials Stocks Moving In Thursday's After-Market Session

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.